Clusterin deficiency is associated with a lack of response to teriflunomide in multiple sclerosis

Sunny Malhotra; Nicolas Fissolo; Carmen Rodríguez-Rivera; Enric Monreal; Marta Montpeyo; Elena Urcelay; Juan Carlos Triviño; María José Pérez-García; Miguel F. Segura; Agustín Pappolla; Jordi Río; Andreu Vilaseca; José Ignacio Fernández Velasco; Andrés Miguez; Carlos Goicoechea; Marta Martinez-Vicente; Luisa M Villar; Xavier Montalban; Manuel Comabella

doi:10.1002/ctm2.1654

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (4) : e1654 DOI: 10.1002/ctm2.1654

LETTER TO THE JOURNAL

Clusterin deficiency is associated with a lack of response to teriflunomide in multiple sclerosis

Author information +

History +

PDF

Cite this article

Download citation ▾

Sunny Malhotra, Nicolas Fissolo, Carmen Rodríguez-Rivera, Enric Monreal, Marta Montpeyo, Elena Urcelay, Juan Carlos Triviño, María José Pérez-García, Miguel F. Segura, Agustín Pappolla, Jordi Río, Andreu Vilaseca, José Ignacio Fernández Velasco, Andrés Miguez, Carlos Goicoechea, Marta Martinez-Vicente, Luisa M Villar, Xavier Montalban, Manuel Comabella. Clusterin deficiency is associated with a lack of response to teriflunomide in multiple sclerosis. Clinical and Translational Medicine, 2024, 14(4): e1654 DOI:10.1002/ctm2.1654

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	RíoJ, Castilló J, RoviraA, et al. Measures in the first year of therapy predict the response to interferon beta in MS. Mult Scler. 2009;15(7):848-853.

[2]	MillerAE. An updated review of teriflunomide's use in multiple sclerosis. Neurodegener Dis Manag. 2021;11(5):387-409.

[3]	Rodríguez-RiveraC, Pérez-CarriónMD, OlavarríaLC, Alguacil LF, MoraMJP, González-MartínC. Clusterin levels in undernourished SH-SY5Y cells. Food Nutr Res. 2021:65.

[4]	LeeJ, HongSW, KwonH, et al. Resveratrol, an activator of SIRT1, improves ER stress by increasing clusterin expression in HepG2 cells. Cell Stress Chaperones. 2019;24(4):825-833.

[5]	KlotzL, Eschborn M, LindnerM, et al. Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects. Sci Transl Med. 2019;11(490):eaao5563.

[6]	LiN, Zoubeidi A, BeraldiE, GleaveME. GRP78 regulates clusterin stability, retrotranslocation and mitochondrial localization under ER stress in prostate cancer. Oncogene. 2013;32(15):1933-1942.

[7]	Peña-BlancoA, García-Sáez AJ. Bax, Bak and beyond—mitochondrial performance in apoptosis. FEBS J. 2018;285(3):416-431.

[8]	LiL, LiuJ, DeloheryT, Zhang D, ArendtC, JonesC. The effects of teriflunomide on lymphocyte subpopulations in human peripheral blood mononuclear cells in vitro. J Neuroimmunol. 2013;265(1-2):82-90.

[9]	Bar-OrA. Teriflunomide (Aubagio^(R)) for the treatment of multiple sclerosis. Exp Neurol. 2014;262:57-65. Pt A.

[10]	MoonH-J, Herring SK, ZhaoL. Clusterin: a multifaceted protein in the brain. Neural Regen Res. 2021;16(7):1438-1439.

RIGHTS & PERMISSIONS

2024 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.